Genotype and Phenotype Heterogeneity in Neonatal Diabetes: A Single Centre Experience in Turkey
Neonatal diabetes
genetic
sulfonylurea
monogenic diabetes
potassium channel
syndromic neonatal diabetes
Journal
Journal of clinical research in pediatric endocrinology
ISSN: 1308-5735
Titre abrégé: J Clin Res Pediatr Endocrinol
Pays: Turkey
ID NLM: 101519456
Informations de publication
Date de publication:
26 02 2021
26 02 2021
Historique:
entrez:
22
8
2020
pubmed:
22
8
2020
medline:
3
11
2021
Statut:
ppublish
Résumé
Neonatal diabetes mellitus (NDM) may be transient or permanent, and the majority is caused by genetic mutations. Early diagnosis is essential to select the patients who will respond to oral treatment. In this investigation, we aimed to present the phenotype and genotype of our patients with NDM and share our experience in a single tertiary center A total of 16 NDM patients from 12 unrelated families are included in the study. The clinical presentation, age at diagnosis, perinatal and family history, consanguinity, gender, hemoglobin A1c, C-peptide, insulin, insulin autoantibodies, genetic mutations, and response to treatment are retrospectively evaluated. The median age at diagnosis of diabetes was five months (4 days-18 months) although six patients with a confirmed genetic diagnosis were diagnosed >6 months. Three patients had Although NDM is defined as diabetes diagnosed during the first six months of life, and a diagnosis of type 1 diabetes is more common between the ages of 6 and 24 months, in rare cases NDM may present as late as 12 or even 24 months of age. Molecular diagnosis in NDM is important for planning treatment and predicting prognosis. Therefore, genetic testing is essential in these patients.
Identifiants
pubmed: 32820876
doi: 10.4274/jcrpe.galenos.2020.2020.0093
pmc: PMC7947723
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
80-87Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Références
N Engl J Med. 2004 Apr 29;350(18):1838-49
pubmed: 15115830
Diabetes Care. 2017 Oct;40(10):e147-e148
pubmed: 28779000
Orphanet J Rare Dis. 2007 Mar 09;2:12
pubmed: 17349054
Best Pract Res Clin Endocrinol Metab. 2008 Feb;22(1):17-40
pubmed: 18279778
Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):200-13
pubmed: 18301398
Eur J Endocrinol. 2015 Jun;172(6):697-705
pubmed: 25755231
Oncotarget. 2017 Nov 20;8(64):108274-108285
pubmed: 29296240
Diabetologia. 2002 Jun;45(6):798-804
pubmed: 12107723
Pediatr Diabetes. 2012 Sep;13(6):499-505
pubmed: 22060631
Cell Metab. 2014 Jan 7;19(1):146-54
pubmed: 24411943
Diabetologia. 2006 Sep;49(9):2210-3
pubmed: 16816952
Acta Diabetol. 2012 Oct;49(5):405-8
pubmed: 21953423
J Clin Endocrinol Metab. 2014 Dec;99(12):E2709-14
pubmed: 25238204
EMBO Rep. 2005 May;6(5):470-5
pubmed: 15864298
Horm Res Paediatr. 2013;80(3):137-46
pubmed: 24051999
Diabetes. 1999 Mar;48(3):460-8
pubmed: 10078544
Diabetologia. 2016 Jun;59(6):1162-6
pubmed: 27033559
Diabetologia. 2011 Jul;54(7):1693-701
pubmed: 21544516
Lancet. 2015 Sep 5;386(9997):957-63
pubmed: 26231457
Nat Genet. 2000 Aug;25(4):406-9
pubmed: 10932183
Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646
pubmed: 29880308
J Pediatr. 1982 May;100(5):731-7
pubmed: 7040622
Lancet Diabetes Endocrinol. 2016 Oct;4(10):862-72
pubmed: 27474216
N Engl J Med. 2006 Aug 3;355(5):467-77
pubmed: 16885550
Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17539-44
pubmed: 15583126
Endocr Rev. 2008 May;29(3):265-91
pubmed: 18436707
Pediatrics. 2016 Sep;138(3):
pubmed: 27540106